Berlin - Delayed Quote EUR
Optimi Health Corp (8BN.BE)
0.1070
+0.0040
+(3.88%)
At close: May 30 at 7:10:03 PM GMT+2
Loading Chart for 8BN.BE
- Previous Close
0.1030 - Open
0.1050 - Bid 0.0880 x --
- Ask 0.1210 x --
- Day's Range
0.1020 - 0.1100 - 52 Week Range
0.0950 - 0.3500 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 8BN.BE
View MorePerformance Overview: 8BN.BE
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
8BN.BE
30.07%
S&P/TSX Composite index (^GSPTSE)
6.31%
1-Year Return
8BN.BE
61.51%
S&P/TSX Composite index (^GSPTSE)
18.59%
3-Year Return
8BN.BE
57.71%
S&P/TSX Composite index (^GSPTSE)
25.12%
5-Year Return
8BN.BE
81.10%
S&P/TSX Composite index (^GSPTSE)
72.29%
Compare To: 8BN.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.1070
+3.88%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0182
+1.11%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0200
0.00%
Mkt Cap CAD 520,478
Industry Drug Manufacturers—Specialty & Generic
0.3849
-2.78%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Mkt Cap undefined -
Industry -
1,457.75
+4.38%
Mkt Cap INR 411.378B
Industry Drug Manufacturers—Specialty & Generic
40.00
-0.74%
Mkt Cap SEK 6.355B
Industry Drug Manufacturers—Specialty & Generic
0.5000
0.00%
Mkt Cap CAD 9.47M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 8BN.BE
View MoreValuation Measures
As of 5/30/2025
Market Cap
9.52M
Enterprise Value
11.24M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
29.78
Price/Book (mrq)
1.88
Enterprise Value/Revenue
34.12
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--